The earnings results for Aytu BioPharma (NASDAQ:AYTU) for Q2 were made public on Tuesday, February 3, 2026 at 04:05 PM.
Here’s a comprehensive overview of the announcement.
Earnings
Aytu BioPharma missed estimated earnings by -162.0%, reporting an EPS of $-1.05 versus an estimate of $-0.4.
Revenue was down $1.06 million from the same period last year.
Historical Earnings Summary
During the previous quarter, …